Elsevier

Clinical Imaging

Volume 51, September–October 2018, Pages 300-306
Clinical Imaging

Multimodality images of myofibroblastoma in the male breast: A case report and a review of the literature

https://doi.org/10.1016/j.clinimag.2018.06.004Get rights and content

Abstract

We report a case of a 58-year-old male diagnosed with myofibroblastoma using mammography, ultrasound, computed tomography (CT) and magnetic resonance imaging (MRI), as well as present a review of the literature. The pathological diagnosis was myofibroblastoma with spindle cell neoplasm with immunoreactivity. Myofibroblastoma is a rare benign disease and there is a lack of reports of multimodality imaging of this disease. We review the imaging features of this rare disease across multiple imaging modalities with pathological correlation, and provide current treatment recommendations as well.

Introduction

Myofibroblastoma of the breast is a rare benign tumor of a mesenchymal origin that is derived from the mammary stromal fibro-/myofibroblasts. These tumors are most commonly described in the 6th to 7th decades of the male breast, with a few cases also reported in postmenopausal women [[1], [2], [3]]. The majority of cases present clinically as movable, nontender palpable masses of the breast. A few reports describe the radiological and -pathological features of myofibroblastoma. We report a case of a 58-year-old man through the use of mammography, ultrasonography, computed tomography (CT) and magnetic resonance imaging (MRI). We also provide a brief pathological review of this entity.

Section snippets

Case report

A 58-year-old male visited our hospital with a palpable mass of the left breast detected 4 months prior. He had no previous medical history although a paternal history of skin cancer was found. He had a history of sonography-guided core needle biopsy for a suspicious chest wall mass at an outside local hospital. A breast ultrasound performed in an outside hospital facility revealed an approximately 5 cm, circumscribed, oval, homogeneously isoechoic mass located in the retromammary fat tissue.

Discussion

Myofibroblastoma is a rare tumor characterized by spindle-shaped mesenchymal cells derived from fibroblasts. Myofibroblastoma of the breast is an extremely rare benign tumor, which might be confused with malignancy, both clinically and radiologically [[4], [5], [6], [7]]. Seventeen patients diagnosed with myofibroblastoma of the breast between 1997 and 2017 are listed in table (Table 1). The list includes 14 male patients and three female patients with a mean age of 64.5 years. The reported

Conflicts of interest

This work received Soonchunhyang University research funding. The authors declare that they have no other competing interests.

References (16)

There are more references available in the full text version of this article.

Cited by (5)

  • Male breast myofibroblastoma: Imaging features and ultrasound-guided core biopsy diagnosis

    2023, Radiology Case Reports
    Citation Excerpt :

    Given the nonspecific radiological appearances, we concur that Tru-cut biopsy is a reliable procedure in order to obtain histological diagnosis before planning complete surgical excision of the lesion [3]. Myofibroblastoma can be treated with local excision mainly for symptomatic relief; local recurrence is not a recognized feature of myofibroblastoma [8,9]. The differential diagnosis of breast masses in males is broad.

  • Myofibroblastoma of the male breast: A case report

    2021, Revista de Senologia y Patologia Mamaria
    Citation Excerpt :

    Typically, spindle cells are arranged in short haphazardly intersecting fascicles or clusters, interrupted by collagen bundles, with a lack of ducts and lobules. Essential elements for diagnosis are the presence of thick hyalinized collagen bundles and low mitotic activity as well as the lack of myoepithelial component and necrosis.6,7 Immunohistochemistry is crucial for the diagnosis of MFB, showing consistently positive immunoreactivity to vimentin and CD34, while the expression of desmin, SMA, bcl-2 and CD99 varies.

  • Sonoelastography findings of myofibroblastoma

    2022, Northern Clinics of Istanbul
  • Breast myofibroblastoma in a male patient

    2021, Gaceta Mexicana de Oncologia

This work received Soonchunhyang University research funding.

View full text